title: A peripheral adrenoceptor-mediated sympathetic mechanism can transform stress-induced analgesia into hyperalgesia.
abstract: BACKGROUND
  Stress has paradoxical effects on pain, causing stress-induced analgesia but also exacerbating pain via poorly understood mechanisms. Adrenergic neurotransmission is integral in pathways that regulate the response to both pain and stress. Hyperalgesia is often associated with enhanced adrenergic sensitivity of primary afferents, but sympathetic nervous system outflow has not been demonstrated to exacerbate pain perception after stress.
  
  
  METHODS
  Rats or C57/BL6 wild-type mice treated with α-2 receptor antagonists or α-2A receptor knockout mice were exposed to ultrasonic noise stress or footshock stress and subsequently tested for hotplate paw withdrawal latencies. The sensory sensitivity of α-2A knockout mice to electrical and chemical stimuli was tested neurophysiologically and behaviorally. The effects of sympatholytic treatments were investigated.
  
  
  RESULTS
  Noise and footshock stressors induced thermal hyperalgesia in rats pretreated systemically with α-2 antagonists. Wild-type mice pretreated with α-2 antagonists and α-2A knockout mice also exhibited thermal hyperalgesia induced by noise stress. Local spinal or intraplantar injection of an α-2 antagonist counteracted stress-induced analgesia without causing hyperalgesia. The α-2A knockout mice had decreased thresholds for peripheral sensitization with sulprostone and for windup of the dorsal horn neuronal response to repetitive electrical stimuli. Stress-induced hyperalgesia was abolished and the sensitization was attenuated by sympathectomy or systemic administration of an α-1-adrenergic antagonist.
  
  
  CONCLUSIONS
  Sympathetic postganglionic nerves can enhance pain sensation via a peripheral α-1-adrenoceptor mechanism when sympathetic outflow is disinhibited. The net effect of stress on pain sensation reflects a balance between descending spinal inhibition and sympathetic outflow that can shift toward pain facilitation when central and peripheral α-2-adrenoceptor inhibitory mechanisms are attenuated.
authors.affiliation: Department of Biological Sciences, Allergan, Inc., Irvine, California, USA.
authors.forename: John E
authors.initials: JE
authors.lastname: Donello
authors.forename: Yun
authors.initials: Y
authors.lastname: Guan
authors.forename: Mingting
authors.initials: M
authors.lastname: Tian
authors.forename: Cynthia V
authors.initials: CV
authors.lastname: Cheevers
authors.forename: Miguel
authors.initials: M
authors.lastname: Alcantara
authors.forename: Sara
authors.initials: S
authors.lastname: Cabrera
authors.forename: Srinivasa N
authors.initials: SN
authors.lastname: Raja
authors.forename: Daniel W
authors.initials: DW
authors.lastname: Gil
mesh_terms: D058669:Adrenergic alpha-2 Receptor Antagonists / Q000633:toxicity*; D000698:Analgesia / Q000379:methods; D000818:Animals; D006930:Hyperalgesia / Q000139:chemically induced* / Q000503:physiopathology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D010147:Pain Measurement / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D018341:Receptors, Adrenergic, alpha-2 / Q000172:deficiency / Q000502:physiology*; D013315:Stress, Psychological / Q000503:physiopathology / Q000523:psychology
chemical_list: D058669:Adrenergic alpha-2 Receptor Antagonists; D018341:Receptors, Adrenergic, alpha-2